A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.
Morning Overview on MSN
Harvard team uses CRISPR to silence extra chromosome 21 in lab
A research team led by geneticist Jeannie Lee at Harvard Medical School, cell biologist Jeanne Lawrence at UMass Chan Medical ...
Gene editing figures to be part of the future of medicine, but a popular system for it has some room for improvement, researchers say. That’s why a team from UC San Diego in La Jolla set out with Yale ...
The new method relies on methyl groups, small chemical tags attached to DNA that regulate whether genes are on or off. This ...
Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that ...
If CRISPR stays active too long, it could cut unintended parts of the genome. To reduce this risk, the researchers designed a self-inactivating CRISPR system. This means that CRISPR edits the gene and ...
-Collaboration brings together complementary capabilities to co-develop and co-commercialize SRSD107, a next generation, long-acting Factor XI (FXI) small interfering RNA (siRNA) for the treatment of ...
Despite a lackluster launch, CASGEVY has significant potential in international markets, bolstering CRISPR's long-term value. Upcoming milestones and updates on CRISPR Therapeutics is currently ...
Gene editing figures to be part of the future of medicine, but a popular system for it has some room for improvement, researchers say. That’s why a team from UC San Diego in La Jolla set out with Yale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results